Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02115724 · ClinicalTrials.gov registry record · NA
Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)
A NA study of Cardiovascular Disease, sponsored by Augusta University.
- Active
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT02115724 is a NA study of Cardiovascular Disease that is active but no longer recruiting, run by Augusta University. The registered enrollment target is 74 participants, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02115724, a NA study of Cardiovascular Disease, is active but no longer recruiting, sponsored by Augusta University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiovascular disease is the leading cause of death in the United States. Other studies have shown that stress, early in life, could be a risk factor for cardiovascular disease, later in life. This study will look at the effect of early life stressors on your cardiovascular health.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Antioxidant cocktail
- OTHER Biopsy
- DRUG NMD; 0.4mg sub-lingual nitroglycerin spray
Study Locations (1)
Georgia
- Georgia Prevention Institute , Georgia Regents University - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2014-04 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02115724
The ClinicalTrials.gov registry entry for NCT02115724 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (97% lower). The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiovascular Disease appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT02115724 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT02115724 about?
NCT02115724 is a clinical study titled "Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)". Cardiovascular disease is the leading cause of death in the United States. Other studies have shown that stress, early in life, could be a risk factor for cardiovascular disease, later in life. This study will look at the effect of early life stressors on your cardiovascular health.
What is the current status of trial NCT02115724?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 74 participants. The study started on 2014-04. Estimated completion is 2027-01.
What conditions does trial NCT02115724 study?
This clinical trial studies the following conditions: Cardiovascular Disease.
What interventions are being tested in trial NCT02115724?
The interventions under investigation include: Placebo (OTHER), Antioxidant cocktail (DIETARY_SUPPLEMENT), Biopsy (OTHER), NMD; 0.4mg sub-lingual nitroglycerin spray (DRUG).
Who is sponsoring clinical trial NCT02115724?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02115724 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
RECRUITING · NA
-
A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
RECRUITING · NA
-
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
RECRUITING · NA
-
Determining the Benefits of Exercise on Cardiovascular Risk in PTSD
RECRUITING · NA
-
Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease
ACTIVE NOT RECRUITING · NA
-
Home-Based Measures of Physical Activity and Body Composition
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.